These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30814081)

  • 21. Adiponectin levels and insulin resistance among patients with chronic hepatitis C.
    Carvalho RF; Atta AM; de Oliveira IS; Santos TPS; Santos JPA; Schinoni MI; de Sousa-Atta MLB
    Acta Trop; 2018 Feb; 178():258-263. PubMed ID: 29217381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D Insufficiency Predicts Elevated Levels of Complement 3 Independent of Insulin Resistance and BMI.
    Al Haj Ahmad RM; Al-Domi HA
    J Nutr Sci Vitaminol (Tokyo); 2017; 63(3):155-160. PubMed ID: 28757528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of serum dihomo-γ-linolenic acid level and estimated Δ-5 desaturase activity in patients with hepatic steatosis.
    Matsuda M; Kawamoto T; Tamura R
    Obes Res Clin Pract; 2017; 11(1):34-43. PubMed ID: 26964726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.
    Aksu HS; Kurtaran B; Onlen Y; Namiduru M; Inkaya AC; Kandemir O; Doran F; Evirgen O; Alpay Y; Tekin SK; Kurekci Y; Unlu B; Midikli D; Taşova Y; Ozdener F; Erdogan S
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1393-9. PubMed ID: 23114743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic syndrome and insulin resistance in patients with chronic hepatitis C].
    Baĭzhanova ZhZh; Ignatova TM; Nekrasova TP
    Ter Arkh; 2010; 82(10):51-6. PubMed ID: 21341465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
    Cua IH; Hui JM; Kench JG; George J
    Hepatology; 2008 Sep; 48(3):723-31. PubMed ID: 18688878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with insulin resistance.
    Yesilova Z; Ozata M; Oktenli C; Bagci S; Ozcan A; Sanisoglu SY; Uygun A; Yaman H; Karaeren N; Dagalp K
    Am J Gastroenterol; 2005 Apr; 100(4):842-9. PubMed ID: 15784030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis.
    Liu Z; Que S; Zhou L; Zheng S; Romeo S; Mardinoglu A; Valenti L
    Sci Rep; 2017 Aug; 7(1):9273. PubMed ID: 28839198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C.
    Lo Iacono O; Venezia G; Petta S; Mineo C; De Lisi S; Di Marco V; Rodolico V; Amato M; Ferraro D; Giordano C; Almasio PL; Craxí A
    Aliment Pharmacol Ther; 2007 May; 25(10):1181-91. PubMed ID: 17451564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients.
    Adinolfi LE; Utili R; Ruggiero G
    Hepatology; 1999 Dec; 30(6):1530-1. PubMed ID: 10610353
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.
    Fartoux L; Poujol-Robert A; Guéchot J; Wendum D; Poupon R; Serfaty L
    Gut; 2005 Jul; 54(7):1003-8. PubMed ID: 15951550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum α-fetoprotein levels in patients with chronic hepatitis C virus genotype 4: not the end of the story.
    Abdel-Razik A; Mousa N; Abdel-Aziz M; Elhelaly R; Elzehery R; Zalata K; Elkashef W; Fouda O; Awad M; Hafez M; Eldars W
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):313-22. PubMed ID: 26618566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic steatosis in genotype 4 chronic hepatitis C patients: implication for therapy.
    Khattab MA; Abdel-fattah ME; Eslam M; Abdelaleem A; Abdelaleem RA; Shatat M; Ali A; Hamdy L; Tawfek H
    J Clin Gastroenterol; 2010; 44(10):707-12. PubMed ID: 20195166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fat, diabetes, and liver injury in chronic hepatitis C.
    Ratziu V; Trabut JB; Poynard T
    Curr Gastroenterol Rep; 2004 Feb; 6(1):22-9. PubMed ID: 14720450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.